NCT00982566 Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT00973973 Efficacy and Safety Study of Elagolix in Women With Endometriosis Status COMPLETED Phase PHASE2
NCT00908544 New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients Status COMPLETED Phase NA
NCT00891605 Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00888693 A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT00887757 Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00870740 Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00850044 Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1 Status COMPLETED Phase PHASE1
NCT00797225 Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis Status COMPLETED Phase PHASE2
NCT00788684 Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers Status COMPLETED Phase PHASE1
NCT00696904 Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects Status COMPLETED Phase PHASE1
NCT00660673 Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Status COMPLETED Phase PHASE3
NCT00654758 A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT00650156 Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT00619866 An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis Status COMPLETED Phase PHASE2
NCT00526617 A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients Status COMPLETED Phase PHASE1
NCT00481091 A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE1/PHASE2